Global Drugs for Herpes Labialis (Oral Herpes) Competitive Landscape Professional Research Report 2024

Research Summary

Drugs for herpes labialis, commonly known as oral herpes or cold sores, are medications used to manage and alleviate the symptoms caused by the herpes simplex virus type 1 (HSV-1). These drugs include antiviral medications, such as topical creams or ointments containing ingredients like acyclovir, penciclovir, or docosanol, which aim to reduce the severity and duration of outbreaks. Oral antiviral medications, like valacyclovir or famciclovir, may also be prescribed in more severe or frequent cases to accelerate healing and suppress viral replication. While these drugs cannot completely eradicate the virus, they can help alleviate discomfort, minimize the duration of outbreaks, and potentially reduce the frequency of future occurrences of oral herpes.

According to DIResearch's in-depth investigation and research, the global Drugs for Herpes Labialis (Oral Herpes) market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.

The major global manufacturers of Drugs for Herpes Labialis (Oral Herpes) include GSK, Novartis, Teva, Mylan, Cadila, Apotex, Livzon, Daewoong Pharmaceutical, Med shine, Luoxin, Bayer (Campho Phenique), Blistex, Kelun, Hikma, Haiwang, Carmex, Cipher etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Drugs for Herpes Labialis (Oral Herpes). Focus on analysing the market share, product portfolio, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Drugs for Herpes Labialis (Oral Herpes) market. The report data covers historical data from 2019 to 2023, base year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Drugs for Herpes Labialis (Oral Herpes) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Drugs for Herpes Labialis (Oral Herpes) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Drugs for Herpes Labialis (Oral Herpes) Include:

GSK

Novartis

Teva

Mylan

Cadila

Apotex

Livzon

Daewoong Pharmaceutical

Med shine

Luoxin

Bayer (Campho Phenique)

Blistex

Kelun

Hikma

Haiwang

Carmex

Cipher

Drugs for Herpes Labialis (Oral Herpes) Product Segment Include:

Aciclovir

Valacyclovir

Famciclovir

Docosanol

Other

Drugs for Herpes Labialis (Oral Herpes) Product Application Include:

External Use

Oral

Injection

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Drugs for Herpes Labialis (Oral Herpes) Industry PESTEL Analysis

Chapter 3: Global Drugs for Herpes Labialis (Oral Herpes) Industry Porter's Five Forces Analysis

Chapter 4: Global Drugs for Herpes Labialis (Oral Herpes) Major Regional Market Size and Forecast Analysis

Chapter 5: Global Drugs for Herpes Labialis (Oral Herpes) Market Size and Forecast by Type and Application Analysis

Chapter 6: North America Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 7: Europe Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: China Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: APAC (Excl. China) Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: Latin America Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Global Drugs for Herpes Labialis (Oral Herpes) Competitive Analysis of Key Manufacturers (Revenue, Market Share, Regional Distribution and Industry Concentration)

Chapter 13: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)

Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 15: Research Findings and Conclusion

Chapter 16: Methodology and Data Sources

Table of Contents

1 Drugs for Herpes Labialis (Oral Herpes) Market Overview

1.1 Product Definition and Statistical Scope

1.2 Drugs for Herpes Labialis (Oral Herpes) Product by Type

1.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type, 2023 VS 2024 VS 2030

1.2.2 Aciclovir

1.2.3 Valacyclovir

1.2.4 Famciclovir

1.2.5 Docosanol

1.2.6 Other

1.3 Drugs for Herpes Labialis (Oral Herpes) Product by Application

1.3.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application, 2023 VS 2024 VS 2030

1.3.2 External Use

1.3.3 Oral

1.3.4 Injection

1.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Revenue Analysis (2019-2030)

1.5 Drugs for Herpes Labialis (Oral Herpes) Market Development Status and Trends

1.5.1 Drugs for Herpes Labialis (Oral Herpes) Industry Development Status Analysis

1.5.2 Drugs for Herpes Labialis (Oral Herpes) Industry Development Trends Analysis

2 Drugs for Herpes Labialis (Oral Herpes) Market PESTEL Analysis

2.1 Political Factors Analysis

2.2 Economic Factors Analysis

2.3 Social Factors Analysis

2.4 Technological Factors Analysis

2.5 Environmental Factors Analysis

2.6 Legal Factors Analysis

3 Drugs for Herpes Labialis (Oral Herpes) Market Porter's Five Forces Analysis

3.1 Competitive Rivalry

3.2 Threat of New Entrants

3.3 Bargaining Power of Suppliers

3.4 Bargaining Power of Buyers

3.5 Threat of Substitutes

4 Global Drugs for Herpes Labialis (Oral Herpes) Market Analysis by Regions

4.1 Drugs for Herpes Labialis (Oral Herpes) Overall Market: 2023 VS 2024 VS 2030

4.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Forecast Analysis (2019-2030)

4.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Revenue and Market Share by Region (2019-2024)

4.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Revenue Forecast by Region (2025-2030)

5 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type and Application

5.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

5.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

6 North America

6.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth Rate Analysis (2019-2030)

6.2 North America Key Manufacturers Analysis

6.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

6.4 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

6.5 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

6.5.1 US

6.5.2 Canada

7 Europe

7.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth Rate Analysis (2019-2030)

7.2 Europe Key Manufacturers Analysis

7.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

7.4 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

7.5 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

7.5.1 Germany

7.5.2 France

7.5.3 United Kingdom

7.5.4 Italy

7.5.5 Spain

7.5.6 Benelux

8 China

8.1 China Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth Rate Analysis (2019-2030)

8.2 China Key Manufacturers Analysis

8.3 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

8.4 China Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

9 APAC (excl. China)

9.1 APAC (excl. China) Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth Rate Analysis (2019-2030)

9.2 APAC (excl. China) Key Manufacturers Analysis

9.3 APAC (excl. China) Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

9.4 APAC (excl. China) Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

9.5 APAC (excl. China) Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

9.5.1 Japan

9.5.2 South Korea

9.5.3 India

9.5.4 Australia

9.5.5 Indonesia

9.5.6 Vietnam

9.5.7 Malaysia

9.5.8 Thailand

10 Latin America

10.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth Rate Analysis (2019-2030)

10.2 Latin America Key Manufacturers Analysis

10.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

10.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

10.5 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

10.5.1 Mecixo

10.5.2 Brazil

11 Middle East & Africa

11.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size and Growth Rate Analysis (2019-2030)

11.2 Middle East & Africa Key Manufacturers Analysis

11.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Type

11.4 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Application

11.5 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country

11.5.1 Saudi Arabia

11.5.2 South Africa

12 Market Competition by Manufacturers

12.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Revenue by Key Manufacturers (2020-2024)

12.2 Drugs for Herpes Labialis (Oral Herpes) Competitive Landscape Analysis and Market Dynamic

12.2.1 Drugs for Herpes Labialis (Oral Herpes) Competitive Landscape Analysis

12.2.2 Global Key Manufacturers Headquarter and Key Area Sales

12.2.3 Market Dynamic

13 Key Companies Analysis

13.1 GSK

13.1.1 GSK Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.1.2 GSK Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.2 Novartis

13.2.1 Novartis Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.2.2 Novartis Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.3 Teva

13.3.1 Teva Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.3.2 Teva Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.4 Mylan

13.4.1 Mylan Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.4.2 Mylan Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.5 Cadila

13.5.1 Cadila Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.5.2 Cadila Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.6 Apotex

13.6.1 Apotex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.6.2 Apotex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.7 Livzon

13.7.1 Livzon Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.7.2 Livzon Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.7.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.8 Daewoong Pharmaceutical

13.8.1 Daewoong Pharmaceutical Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.8.2 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.8.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.9 Med shine

13.9.1 Med shine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.9.2 Med shine Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.9.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.10 Luoxin

13.10.1 Luoxin Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.10.2 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.10.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.11 Bayer (Campho Phenique)

13.11.1 Bayer (Campho Phenique) Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.11.2 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.12 Blistex

13.12.1 Blistex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.12.2 Blistex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.13 Kelun

13.13.1 Kelun Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.13.2 Kelun Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.14 Hikma

13.14.1 Hikma Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.14.2 Hikma Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.15 Haiwang

13.15.1 Haiwang Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.15.2 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.16 Carmex

13.16.1 Carmex Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.16.2 Carmex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

13.17 Cipher

13.17.1 Cipher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)

13.17.2 Cipher Drugs for Herpes Labialis (Oral Herpes) Product Portfolio

13.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Market Data Analysis (Revenue, Gross Margin and Market Share) (2020-2024)

14 Industry Chain Analysis

14.1 Drugs for Herpes Labialis (Oral Herpes) Industry Chain Analysis

14.2 Drugs for Herpes Labialis (Oral Herpes) Industry Raw Material and Suppliers Analysis

14.2.1 Upstream Key Raw Material Supply Analysis

14.2.2 Raw Material Suppliers and Contact Information

14.3 Drugs for Herpes Labialis (Oral Herpes) Typical Downstream Customers

14.4 Drugs for Herpes Labialis (Oral Herpes) Sales Channel Analysis

15 Research Findings and Conclusion

16 Methodology and Data Source

16.1 Methodology/Research Approach

16.2 Research Scope

16.3 Benchmarks and Assumptions

16.4 Date Source

16.4.1 Primary Sources

16.4.2 Secondary Sources

16.5 Data Cross Validation

16.6 Disclaimer

Name*

Email ID*

Company*

Phone (With Country Code)*

What is/are your question(s)?:

Publisher: DIResearch

Related Reports

Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)

Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)

Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)

Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035

Why Market Study Report?

Best Price for Reports
Large Report Database
Easily Customize Reports
24/7 Email & Phone Support